Intervention

resveratrol

ClinicalTrials.gov intervention label

Clinical trials6

Recruiting0

Common conditions11

Lead sponsors shown4

Clinical trials

6 shown

Long-term Resveratrol and MetabolismNCT02565979 · 2016-04-01

Resveratrol and First-degree Relatives of Type 2 Diabetic PatientsNCT02129595 · 2014-04-01

Resveratrol, Cardiovascular Risk Markers And Cognitive Performance In Patients With SchizophreniaNCT02062190 · 2014-03-01

Effects of Resveratrol on Inflammation in Type 2 Diabetic PatientsNCT02244879 · 2013-10-01

Resveratrol and Type 2 DiabetesNCT01638780 · 2012-05-01

Effect of Resvida, a Comparison With Calorie Restriction RegimenNCT00823381 · 2009-01-01

Common conditions

Pre-diabetes2 Aging1 Diabetes1 Inflammation1 Insulin Resistance1 Metabolic Syndrome1 Obesity1 Other Disorders of Bone Density and Structure1 Schizophrenia1 Type 2 Diabetes1 Type 2 Diabetes Mellitus1

Leading sponsors

Maastricht University Medical Center3 Federal University of Rio Grande do Sul1 University of Turin, Italy1 Washington University School of Medicine1

Trial status mix

COMPLETED5

UNKNOWN1

Phase mix

NA4

PHASE21

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.